Response to Letters Regarding Article, "Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: A Target of Phosphodiesterase-5 Inhibition in a 1-Year Study"

被引：0
|
作者：
Guazzi, Marco [1 ]
Vicenzi, Marco [1 ]
Arena, Ross [2 ]
Guazzi, Maurizio D. [3 ]
机构：
[1] Univ Milan, Cardiopulm Unit, Milan, Italy
[2] Univ New Mexico, Dept Phys Therapy, Albuquerque, NM 87131 USA
[3] Univ Milan, Dept Cardiol, Milan, Italy
来源：
CIRCULATION | 2012年 / 125卷 / 08期
关键词：
D O I：
10.1161/CIRCULATIONAHA.111.072090
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E409 / E410
页数：2
相关论文
共 50 条
  • [31] PREDICTORS OF ABNORMAL EXERCISE PULMONARY VASCULAR RESISTANCE RESPONSE IN PULMONARY ARTERIAL HYPERTENSION AND HEART FAILURE WITH PRESERVED EJECTION FRACTION
    Garcia-Arango, Mariana
    Kristo, Angela
    El Shaer, Ahmed
    Heffernan, Shannon
    Esmaeeli, Amirhossein
    Tao, Ran
    Dharmavaram, Naga
    Runo, James
    Raza, Farhan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 2101 - 2101
  • [32] Letter by Dai et al Regarding Article, "Tadalafil for Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension in Patients With Heart Failure and Preserved Ejection Fraction"
    Dai, Hailong
    Lu, Xiangting
    Zhou, Xu
    CIRCULATION, 2025, 151 (10) : e686 - e686
  • [33] Treatment of Pulmonary Arterial Hypertension Associated With Heart Failure With Preserved Ejection Fraction: A Pilot Study of Ranolazine
    Farber, Harrison
    Finch, Kimberly
    Stratton, Eric
    CHEST, 2013, 144 (04)
  • [34] Altered Heart Rate Turbulence and Variability Parameters Predict 1-Year Mortality in Heart Failure with Preserved Ejection Fraction
    Ksela, Jus
    Rupert, Lea
    Djordjevic, Anze
    Antonic, Miha
    Avbelj, Viktor
    Jug, Borut
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2022, 9 (07)
  • [35] Therapeutic potential of phosphodiesterase type 5 inhibitors in heart failure with preserved ejection fraction and combined post- and pre-capillary pulmonary hypertension
    Kramer, Tilmann
    Dumitrescu, Daniel
    Gerhardt, Felix
    Orlova, Kristina
    ten Freyhaus, Henrik
    Hellmich, Martin
    Baldus, Stephan
    Rosenkranz, Stephan
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 283 : 152 - 158
  • [36] Letter by Komamura Regarding Article, "Treatment With Treprostinil and Metformin Normalizes Hyperglycemia and Improves Cardiac Function in Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction"
    Komamura, Kazuo
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2020, 40 (10) : E273 - E273
  • [37] Prevalence and prognostic significance of pulmonary hypertension in heart failure with preserved ejection fraction: A population-based study
    Lam, Carolyn S. P.
    Roger, Veronique L.
    Rodeheffer, Richard R.
    Borlaug, Barry A.
    Redfield, Margaret M.
    JOURNAL OF CARDIAC FAILURE, 2008, 14 (06) : S16 - S17
  • [38] Clinical characteristics and prognostic impact of pulmonary hypertension in heart failure with preserved ejection fraction: the PURSUIT HFpEF study
    Sera, F.
    Ohtani, T.
    Nakamoto, K.
    Yamada, T.
    Yasumura, Y.
    Tamaki, S.
    Hayashi, T.
    Yano, M.
    Hikoso, S.
    Yamauchi-Takihara, K.
    Sakata, Y.
    EUROPEAN HEART JOURNAL, 2020, 41 : 2286 - 2286
  • [39] Prognosis of heart failure with preserved ejection fraction:: a 5 year prospective population-based study
    Tribouilloy, Christophe
    Rusinaru, Dan
    Mahjoub, Haifa
    Souliere, Vicky
    Levy, Franck
    Peltier, Marcel
    Slama, Michel
    Massy, Ziad
    EUROPEAN HEART JOURNAL, 2008, 29 (03) : 339 - 347
  • [40] Phosphodiesterase 5 inhibitor sildenafil in patients with heart failure with preserved ejection fraction and combined pre- and postcapillary pulmonary hypertension: a randomized open-label pilot study
    Belyavskiy, Evgeny
    Ovchinnikov, Artem
    Potekhina, Alexandra
    Ageev, Fail
    Edelmann, Frank
    BMC CARDIOVASCULAR DISORDERS, 2020, 20 (01)
12345